Results showed that compared to normal tissues, the expression of S100A3, S100A4, S100A6, S100A8, S100A9, S100A10, S100A11, and S100A16 was upregulated in CNS cancer tissues, while S100A1 and S100A13 were downregulated (Figure 1). This evidence concerns the gene S100A11 and central nervous system cancer.